Health Care / Hospitals
Releases published in the last 30 days. 
Page 1 of 4
- Aon says Equitable Life announcement is a prompt for DC trustees to review scheme arrangements
- 6/19/2018 9:50:50 AM
- Aon, the leading global professional services firm providing a broad range of risk, retirement and health solutions, has said that today’s announcement from Equitable Life that it is transferring all its policies to Reliance Life, should act as a prompt to defined contribution (DC) scheme trustees to revisit their strategy for legacy providers of additional voluntary …
- Strict biosecurity recommended in the fight against African Swine Fever
- 6/19/2018 2:43:20 AM
- With African Swine Fever (ASF) continuing its spread through Eastern and Central Europe and industry leaders warning pig producers about an increased risk of ASF reaching the UK, specialty chemicals company LANXESS is recommending the implementation of strict biosecurity protocols to help prevent the spread of the disease.
- New long-term data confirm Roche’s Gazyva/Gazyvaro extends the lives of people with chronic lymphocytic leukaemia compared to MabThera/Rituxan
- 6/18/2018 12:14:39 PM
- • After a follow-up time of nearly five years the CLL11 study shows a 51% reduction in the risk of disease progression or death with Gazyva/Gazyvaro compared to MabThera/Rituxan • The final analysis reports a clinically meaningful overall survival benefit is seen for Gazyva/Gazyvaro compared to MabThera/Rituxan when combined with chlorambucil • These data highlight …
- ViiV Healthcare reports landmark phase III studies for dolutegravir and lamivudine, demonstrating the ability to control HIV with a two-drug regimen in treatment naïve patients
- 6/18/2018 12:10:08 PM
- ViiV Healthcare today announced positive headline results from its phase III GEMINI study programme. The studies (GEMINI-1 and GEMINI-2) are designed to evaluate the safety and efficacy of a two-drug regimen (2DR) of dolutegravir and lamivudine compared to a three-drug regimen of dolutegravir and two nucleoside reverse transcriptase inhibitors, tenofovir disoproxil …
- Hong Kong’s Government Flying Service receive first H175s in public services configuration
- 6/18/2018 11:46:04 AM
- Hong Kong based Government Flying Service (GFS) has received three H175s in public services configuration, becoming the world’s first operator of this new variant which enlarges the H175 mission capacity to search and rescue (SAR), emergency medical services, law enforcement, firefighting as well as land and maritime border control operations.
- Philips-commissioned Future Health Index outlines journey to value-based healthcare
- 6/18/2018 11:33:02 AM
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released the first chapter of the 2018 Future Health Index (FHI), a research-based platform designed to help determine the readiness of countries to address global health challenges and build efficient and effective health systems.
- Eni signs agreement with Poison Control Centre at the ICS Maugeri Clinical Scientific Institute to make partnership global
- 6/15/2018 10:39:30 AM
- Eni and ICS Maugeri have signed an agreement to expand their partnership in toxicological emergency research, prevention and treatment to all the countries where Eni operates.
- Many fathers are unaware of the parental leave options available to them.
- 6/15/2018 3:38:17 AM
- Research by Aviva in the UK shows: • Half of working fathers haven’t heard of shared parental leave. • Nine out of 10 parents believe mums and dads should be given equal parental leave. • Most fathers take less than a month off work when a child arrives.
- Marvin Mack Develops Course for Personal and Professional Development for Individual and Organizational Uses
- 6/15/2018
- If a seedling stays a seedling in its entire lifetime, it would never be able to taste success of becoming a huge tree. In the same way, if a person stays as he is, he would never attain success.
- Honey May Reduce Injury in Children Who Have Swallowed Button Batteries
- 6/14/2018 11:37:55 AM
- Ingestion of button batteries, which are frequently found in the household setting, can rapidly lead to caustic esophageal injury in infants and children.
- Solvay’s high-stiffness Ixef® PARA enables Reign Medical to develop a more robust compression staple system for orthopedic and podiatric surgeries
- 6/14/2018 11:07:53 AM
- Solvay, a leading global supplier of specialty polymers, announced today that its Ixef® polyarylamide (PARA) resin delivered the high stiffness and biocompatibility that Reign Medical needed to develop its revolutionary new Clench® compression staple system, a single-use bone staple kit for orthopedic procedures targeting the hand and foot.
- Kaiser Permanente and Emory Healthcare Announce New Collaboration for Integrated Care
- 6/14/2018 11:03:21 AM
- Emory Healthcare, the clinical arm of Emory University, and Kaiser Permanente will collaborate to develop a new care model that provides Kaiser Permanente members with a fully integrated health care experience, and in the process advances patient- and family-centered care in metro Atlanta and beyond.
- Author Carolyn T. Linn Shares Her Own Painful Story in Dealing with Her Husband’s Illness
- 6/14/2018 8:00:00 AM
- Carolyn T. Linn shares her remarkable dedication to her husband and God. When her husband was diagnosed with schizophrenia, she turned to God for guidance and inspiration.
- Regional Dentistry Practice Launches New Informational Website
- 6/13/2018 9:11:18 PM
- Coulter Family Dentistry today announced the complete redesign and relaunch of the practice’s website with expanded content and videos providing information on the latest dental technologies and techniques allowing for painless implants, crowns, gingival grafting, bonding and root canals, in a comfortable, relaxed setting.
- Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making
- 6/13/2018 12:56:08 PM
- Over the past decade, advances in our understanding of the basic biology of serious and life-threatening diseases has led to the development and FDA approval of targeted treatments for patients with a specific molecular sub-type.
- WHO certifies Paraguay malaria-free
- 6/13/2018 12:54:14 PM
- The World Health Organization (WHO) today certified Paraguay as having eliminated malaria, the first country in the Americas to be granted this status since Cuba in 1973.
- Future Family Appoints Ex-SolarCity VP West Owens as Chief Financial Officer to Expand Its Subscription-based Fertility Service
- 6/13/2018 12:47:59 PM
- Today Future Family, the leading fertility care platform for consumers in the US, announces the appointment of West Owens as its Chief Financial Officer.
- Political Standoff in the Mediterranean Puts Vulnerable People at Risk
- 6/13/2018 12:39:57 PM
- UPDATE: The Aquarius has transferred rescued people to Italian coast guard and navy vessels, leaving 51 women, 45 men and 10 children onboard the Aquarius.
- More Big MPS Deals Reported Among Xerox Channel Partners
- 6/13/2018 12:25:14 PM
- Two recent signings provide further evidence that channel partners are finding growth opportunities with Xerox’s Managed Print Services (MPS). Multi-brand print dealer Alberta Printer Service won a four-year, $450,000 contract with an agriculture and construction equipment consolidator in western Canada.
- Men’s Health Week: spotlight on sugar
- 6/13/2018 11:54:39 AM
- Men’s Health Week is run by Men’s Health Forum to raise awareness about health issues affecting the UK’s male population. This year the focus is on the UK’s diabetes crisis, estimated to affect one in ten men in the UK – a figure expected to increase sharply over the next 20 years.
